The Company’s therapeutic approach is to administer agents that stimulate proliferation and differentiation of adult stem cells to regenerate lost, damaged or diseased tissue. Our technology will allow for the regrowth of functional cells from the patients' own inherent, but dormant, stem cell populations. With this approach, we hope to avoid the uncertainties and ethical concerns surrounding the therapeutic use of embryonic stem cells.